HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].

AbstractBACKGROUND:
Beyond intraocular pressure (IOP, German abbreviation: IOD) ocular perfusion is increasingly discussed in the pathogenesis of the glaucomas. The present study was designed to investigate for ocular pulse amplitude (OPA) in primary open angle glaucoma patients with elevated intraocular pressure (POAG, German abbreviation: POWG) following application of timolol, a beta-blocker and dorzolamide a topical carbonic anhydrase inhibitor.
METHODS:
OPA (Ocular Blood Flow System, OBF Labs U.K.) IOP, heart rate, systolic and diastolic brachial artery pressures were measured before and 4 weeks following application of timolol and additional 4 weeks following application of a timolol/dorzolamide combination in 14 POAG patients.
RESULTS:
Following administration of timolol, IOP was highly significantly reduced in drug treated POAG eyes; this effect was additively enhanced by dorzolamide. Timolol did not affect OPA, whereas dorzolamide significantly increased OPA in drug treated POAG eyes. Systemic perfusion parameters were unchanged.
CONCLUSION:
Timolol and dorzolamide drastically reduced IOP, in addition dorzolamide increased OPA in POAG, an ocular microcirculatory effect which may further help to improve prognosis of POAG.
AuthorsK G Schmidt, A von Rückmann, R Becker, L E Pillunat
JournalKlinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 215 Issue 6 Pg. 361-6 (Dec 1999) ISSN: 0023-2165 [Print] Germany
Vernacular TitleOkuläre Pulsamplitude, intraokulärer Druck und Betablocker/Karboanhydrasehemmung in der Kombinationstherapie beim primären Offenwinkelglaukom.
PMID10637801 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-Antagonists
  • Carbonic Anhydrase Inhibitors
  • Ophthalmic Solutions
  • Sulfonamides
  • Thiophenes
  • Timolol
  • dorzolamide
Topics
  • Adrenergic beta-Antagonists (administration & dosage, adverse effects)
  • Aged
  • Blood Pressure (drug effects, physiology)
  • Carbonic Anhydrase Inhibitors (administration & dosage, adverse effects)
  • Drug Therapy, Combination
  • Eye (blood supply)
  • Female
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Intraocular Pressure (drug effects, physiology)
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Pulsatile Flow (drug effects, physiology)
  • Sulfonamides (administration & dosage, adverse effects)
  • Thiophenes (administration & dosage, adverse effects)
  • Timolol (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: